New Score for Pseudo- Acanthosis Nigricans
Use Of A Novel Quantitative Tool For Evaluation of Pseudo- Acanthosis Nigricans: Acanthosis Nigricans Area And Severity Index
1 other identifier
interventional
20
1 country
1
Brief Summary
Each side of the neck pseudo acanthosis nigricans was randomized in to either receiving glycolic acid peel or saline. Evaluation was done at baseline and after 3 sessions 2 weeks apart by percentage involvement and by ANASI score
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 21, 2020
CompletedFirst Posted
Study publicly available on registry
April 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedApril 24, 2020
April 1, 2020
3 months
April 21, 2020
April 22, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Percentage involvement
Degree of severity expressed as a percentage
6 months to 1 year
Acanthosis Nigricans Area and Severity Index score
New Score calculating severity and area as a number minimum value is 0 and maximum value is 40 the higher the number of the score the worse the affection
6 months to 1 year
Study Arms (2)
glycolic acid peel
EXPERIMENTALSaline
PLACEBO COMPARATORInterventions
Glycolic acid peel 70% applied in 3 coats medium depth
Eligibility Criteria
You may qualify if:
- mild to moderate severity
- age \> 18 years old
You may not qualify if:
- Pregnant and lactating patients,
- patients with systemic diseases as connective tissue disease, diabetes,
- skin infection
- use of immunosuppressive drugs
- Susceptibility for post peel hazards as hyperpigmentation
- scarring and keloidal tendency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kasr El Ainy university hospital, Faulty of medicine,Cairo university
Cairo, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 21, 2020
First Posted
April 24, 2020
Study Start
August 1, 2019
Primary Completion
November 1, 2019
Study Completion
June 1, 2020
Last Updated
April 24, 2020
Record last verified: 2020-04